These interpretations are limited, however, by insufficient knowledge and paucity of studies concerning distribution of CCR2 in MS, due to technical reasons such as restricted availability of commercial antibodies, despite the nonredundant role of CCR2 that demonstrated by using animal models. The gene discussed is CCR2; the disease is myeloid sarcoma.